Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Sonoma Pharmaceuticals Inc (SNOA)

Sonoma Pharmaceuticals Inc (SNOA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,497
  • Shares Outstanding, K 15,607
  • Annual Sales, $ 13,270 K
  • Annual Income, $ -5,150 K
  • 60-Month Beta 1.28
  • Price/Sales 0.08
  • Price/Cash Flow N/A
  • Price/Book 0.32
Trade SNOA with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.78
  • Most Recent Earnings $-0.06 on 02/08/24
  • Latest Earnings Date 02/13/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.23
  • Growth Rate Est. (year over year) +434,447.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1371 +16.99%
on 03/26/24
0.1919 -16.41%
on 03/28/24
+0.0204 (+14.57%)
since 03/25/24
3-Month
0.1311 +22.35%
on 03/20/24
0.3178 -49.53%
on 01/31/24
-0.0077 (-4.58%)
since 01/25/24
52-Week
0.1159 +38.40%
on 11/10/23
1.5200 -89.45%
on 06/09/23
-0.8496 (-84.12%)
since 04/25/23

Most Recent Stories

More News
Investors Chat: Instacart IPO

Instacart is profitable and growing. Is that enough to spark investor interest?

LYV : 88.49 (-1.29%)
WMT : 60.21 (+0.57%)
MCD : 275.60 (-0.42%)
DIS : 112.77 (-1.01%)
CPB : 45.37 (-0.37%)
UBER : 69.31 (-0.07%)
DASH : 128.11 (+1.07%)
NFLX : 564.80 (+1.74%)
AMZN : 173.67 (-1.65%)
PEP : 176.68 (-0.41%)
SNOA : 0.1604 (+0.25%)
Augmented Reality Devices: Apple vs. Meta Platforms

Plus, how to plan for a healthier retirement.

AAPL : 169.89 (+0.51%)
TMUS : 164.05 (-0.08%)
META : 441.38 (-10.56%)
SNOA : 0.1604 (+0.25%)
COIN : 223.61 (-0.34%)
VZ : 39.22 (-0.68%)
T : 16.58 (-1.37%)
UBER : 69.31 (-0.07%)
Sonoma Pharmaceuticals (NASDAQ: SNOA) and EMC Pharma Receives DAPA Registration for Microcyn Rx Products from U.S. Department of Defense

Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) is a global healthcare company that is focused on the research, development and production of

SNOA : 0.1604 (+0.25%)
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2022 Financial Results

WOODSTOCK, GA / ACCESSWIRE / July 13, 2022 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA),a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous...

SNOA : 0.1604 (+0.25%)
Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce that U.S. EPA has Added Nanocyn® Hospital-Grade Disinfectant to List N for Use Against COVID-19

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications,...

SNOA : 0.1604 (+0.25%)
Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce EPA Approval for Nanocyn® Hospital-Grade Disinfectant in the U.S.

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications,...

SNOA : 0.1604 (+0.25%)
Sonoma Pharmaceuticals Launches New Urinary Tract Infection Product Through Distributors in New Zealand, Australia and South Africa

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications,...

SNOA : 0.1604 (+0.25%)
Sonoma Pharmaceuticals Reports Third Quarter FY 2022 Financial Results

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye...

SNOA : 0.1604 (+0.25%)
Sonoma Pharmaceuticals Announces Expansion of its Partner Network for Oral and Dental Products in the U.S. and China

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications,...

SNOA : 0.1604 (+0.25%)
Sonoma Pharmaceuticals Reports Second Quarter FY 2022 Financial Results

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye...

SNOA : 0.1604 (+0.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Sonoma Pharmaceuticals operates as a pharmaceutical company. It develops and markets solutions for the treatment of dermatological conditions, animal health and advanced tissue care. The company operates primarily in United States, Latin America and Europe. Sonoma Pharmaceuticals formerly known as Oculus...

See More

Key Turning Points

3rd Resistance Point 0.1789
2nd Resistance Point 0.1744
1st Resistance Point 0.1674
Last Price 0.1604
1st Support Level 0.1559
2nd Support Level 0.1514
3rd Support Level 0.1444

See More

52-Week High 1.5200
Fibonacci 61.8% 0.9836
Fibonacci 50% 0.8180
Fibonacci 38.2% 0.6523
Last Price 0.1604
52-Week Low 0.1159

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar